KalVista Pharmaceuticals, Inc. (Nasdaq:KALV)
Health Care/Life Sciences • Pharmaceuticals
CIK 1348911
Company
KalVista Pharmaceuticals, Inc. is a clinical stage pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for diseases with significant unmet need. Its product candidates are inhibitors of plasma kallikrein being developed for two indications: Sebetralstat for HAE and Factor XIIa. The company was founded by T. Andrew Crockett, Edward P. Feener, and Lloyd Paul Aiello on March 26, 2004 and is headquartered in Cambridge, MA.
Address
55 Cambridge Parkway
Suite 901 East
Cambridge, Massachusetts 02142
55 Cambridge Parkway
Suite 901 East
Cambridge, Massachusetts 02142
Employees
118
118
Stock Info
Key Executives
Board Of Directors
Director, Chief Executive & Financial Officer Benjamin L Palleiko MBA |
Independent Chairman Brian Jude Gerard Pereira MD, MBA |
Independent Director Albert Cha MD, PhD |
Independent Director Edward W Unkart MBA, CPA |
Independent Director Patrick A Treanor MBA |
Independent Director Nancy Stuart MBA |
SEC filings
Date | Form | Event |
---|---|---|
7 Nov, 2024 | SC 13D/A | |
4 Nov, 2024 | 8-K | |
4 Nov, 2024 | 8-K | |
4 Nov, 2024 | 424B5 | |
4 Nov, 2024 | SC 13G/A | |
4 Oct, 2024 | 4 | |
4 Oct, 2024 | 4 | |
4 Oct, 2024 | 8-K | |
4 Oct, 2024 | 4 | |
4 Oct, 2024 | 4 | |
4 Oct, 2024 | 4 | |
11 Sep, 2024 | 4 | |
11 Sep, 2024 | 3 | |
10 Sep, 2024 | 8-K | |
10 Sep, 2024 | 4 | |
5 Sep, 2024 | 8-K | |
5 Sep, 2024 | 10-Q | |
26 Aug, 2024 | 4 | |
26 Aug, 2024 | 4 | |
22 Aug, 2024 | DEFA14A | |
22 Aug, 2024 | DEF 14A | |
22 Aug, 2024 | ARS | |
21 Aug, 2024 | 4 | |
21 Aug, 2024 | 4 | |
21 Aug, 2024 | 4 | |
23 Jul, 2024 | 8-K | |
19 Jul, 2024 | EFFECT | |
17 Jul, 2024 | CORRESP | |
16 Jul, 2024 | 144 | |
16 Jul, 2024 | UPLOAD | |
11 Jul, 2024 | S-3 | |
11 Jul, 2024 | 10-K | |
11 Jul, 2024 | 8-K | |
28 Jun, 2024 | S-8 | |
10 Jun, 2024 | 4 | |
24 May, 2024 | 4 | |
24 May, 2024 | 4 | |
21 May, 2024 | 4 | |
21 May, 2024 | 4 | |
21 May, 2024 | 4 | |
21 May, 2024 | 4 | |
22 Apr, 2024 | 3 | |
22 Apr, 2024 | 8-K | |
22 Apr, 2024 | 4 | |
1 Apr, 2024 | SC 13D/A | |
11 Mar, 2024 | 8-K | |
11 Mar, 2024 | 10-Q | |
8 Mar, 2024 | 4 | |
7 Mar, 2024 | 8-K | CEO Change |
26 Feb, 2024 | SC 13G | |
22 Feb, 2024 | SC 13D/A | |
22 Feb, 2024 | 4 | |
21 Feb, 2024 | 4 | |
21 Feb, 2024 | 4 | |
21 Feb, 2024 | 4 | |
21 Feb, 2024 | 4 | |
21 Feb, 2024 | 4 | |
20 Feb, 2024 | SC 13D/A | |
16 Feb, 2024 | 4 | |
16 Feb, 2024 | 4 | |
16 Feb, 2024 | 4 | |
16 Feb, 2024 | 8-K | |
16 Feb, 2024 | 424B5 | |
16 Feb, 2024 | 4 | |
14 Feb, 2024 | 424B5 | |
14 Feb, 2024 | 8-K | |
14 Feb, 2024 | SC 13G/A | |
14 Feb, 2024 | SC 13G/A | |
13 Feb, 2024 | 4 | |
13 Feb, 2024 | 8-K | |
13 Feb, 2024 | SC 13G/A | |
13 Feb, 2024 | SC 13G | |
13 Feb, 2024 | 4 | |
13 Feb, 2024 | 4 | |
13 Feb, 2024 | 4 | |
13 Feb, 2024 | 4 | |
12 Feb, 2024 | SC 13G | |
9 Feb, 2024 | SC 13G/A | |
8 Feb, 2024 | 4 | |
5 Feb, 2024 | 4 | |
1 Feb, 2024 | 4 | |
29 Jan, 2024 | 4 | |
29 Jan, 2024 | SC 13G | |
24 Jan, 2024 | 4 | |
16 Jan, 2024 | 4 | |
12 Jan, 2024 | 4 | |
10 Jan, 2024 | 4 | |
10 Jan, 2024 | 4 | |
9 Jan, 2024 | S-8 | |
8 Jan, 2024 | 144 | |
5 Jan, 2024 | 4 | |
29 Dec, 2023 | 4 | |
28 Dec, 2023 | SC 13G/A | |
28 Dec, 2023 | 4 | |
28 Dec, 2023 | 3 | |
27 Dec, 2023 | 144 | |
14 Dec, 2023 | SC 13D/A | |
7 Dec, 2023 | 10-Q | |
7 Dec, 2023 | 8-K | |
21 Nov, 2023 | 4 | |
21 Nov, 2023 | 4 | |
21 Nov, 2023 | 4 | |
21 Nov, 2023 | 4 | |
21 Nov, 2023 | 4 | |
1 Nov, 2023 | 4 | |
28 Sep, 2023 | 4 | |
28 Sep, 2023 | 4 | |
28 Sep, 2023 | 4 | |
28 Sep, 2023 | 4 | |
28 Sep, 2023 | 4 | |
28 Sep, 2023 | 8-K | |
13 Sep, 2023 | 4 | |
11 Sep, 2023 | 144 | |
7 Sep, 2023 | 10-Q | |
7 Sep, 2023 | 8-K | |
21 Aug, 2023 | 4 | |
21 Aug, 2023 | 4 | |
21 Aug, 2023 | 4 | |
21 Aug, 2023 | 4 | |
21 Aug, 2023 | 4 | |
14 Aug, 2023 | DEF 14A | |
14 Aug, 2023 | DEFA14A | |
14 Aug, 2023 | ARS | |
4 Aug, 2023 | PRE 14A | |
10 Jul, 2023 | 8-K | |
10 Jul, 2023 | 10-K | |
14 Jun, 2023 | 8-K | |
22 May, 2023 | 4/A | |
22 May, 2023 | 4 | |
22 May, 2023 | 4/A | |
22 May, 2023 | 4/A | |
22 May, 2023 | 4/A | |
22 May, 2023 | 4/A | |
19 May, 2023 | 4 | |
19 May, 2023 | 4 | |
19 May, 2023 | 4 | |
19 May, 2023 | 4 | |
19 May, 2023 | 4 | |
10 Mar, 2023 | SC 13G | |
9 Mar, 2023 | 8-K | |
9 Mar, 2023 | 10-Q | |
23 Feb, 2023 | 4 | |
23 Feb, 2023 | 4 | |
23 Feb, 2023 | 4 | |
23 Feb, 2023 | 4 | |
23 Feb, 2023 | 4 | |
14 Feb, 2023 | SC 13G/A | |
14 Feb, 2023 | SC 13G/A | |
14 Feb, 2023 | SC 13G/A | |
14 Feb, 2023 | SC 13G/A | |
13 Feb, 2023 | SC 13G/A | |
9 Feb, 2023 | SC 13G | |
6 Feb, 2023 | SC 13G/A | |
31 Jan, 2023 | SC 13G/A | |
10 Jan, 2023 | S-8 | |
9 Jan, 2023 | SC 13D | |
9 Jan, 2023 | SC 13G | |
6 Jan, 2023 | SC 13G/A | |
5 Jan, 2023 | 8-K | |
30 Dec, 2022 | SC 13D/A | |
27 Dec, 2022 | 424B5 | |
27 Dec, 2022 | 8-K | |
8 Dec, 2022 | 8-K | |
8 Dec, 2022 | 10-Q | |
21 Nov, 2022 | 4 | |
21 Nov, 2022 | 4 | |
21 Nov, 2022 | 4 | |
21 Nov, 2022 | 4 | |
21 Nov, 2022 | 4 | |
17 Oct, 2022 | 4 | |
17 Oct, 2022 | 8-K | |
17 Oct, 2022 | 4 | |
17 Oct, 2022 | 4 | |
17 Oct, 2022 | 4 | |
11 Oct, 2022 | DEFA14A | |
8 Sep, 2022 | 10-Q | |
8 Sep, 2022 | 8-K | |
7 Sep, 2022 | 4 | |
22 Aug, 2022 | DEFA14A | |
22 Aug, 2022 | DEF 14A | |
19 Aug, 2022 | 4 | |
19 Aug, 2022 | 4 | |
19 Aug, 2022 | 4 | |
19 Aug, 2022 | 4 | |
19 Aug, 2022 | 4 | |
15 Aug, 2022 | SC 13G/A | |
7 Jul, 2022 | 8-K | |
7 Jul, 2022 | 10-K | |
27 May, 2022 | 4 | |
27 May, 2022 | 8-K | |
27 May, 2022 | 3 | |
26 May, 2022 | SC 13G | |
19 May, 2022 | 4 | |
19 May, 2022 | 4 | |
19 May, 2022 | 4 | |
19 May, 2022 | 4 | |
19 May, 2022 | 4 | |
19 May, 2022 | 4 | |
18 May, 2022 | SC 13G | |
11 Mar, 2022 | 4 | |
10 Mar, 2022 | 10-Q | |
10 Mar, 2022 | 8-K | |
10 Mar, 2022 | S-8 | |
7 Mar, 2022 | 8-K | |
14 Feb, 2022 | SC 13G/A | |
14 Feb, 2022 | SC 13G/A | |
14 Feb, 2022 | SC 13G/A | |
14 Feb, 2022 | SC 13G/A | |
11 Feb, 2022 | SC 13G/A | |
11 Feb, 2022 | SC 13G/A | |
11 Feb, 2022 | SC 13G/A | |
10 Feb, 2022 | SC 13D/A | |
4 Feb, 2022 | SC 13G | |
4 Feb, 2022 | SC 13G | |
1 Feb, 2022 | SC 13G/A | |
31 Jan, 2022 | SC 13D/A | |
11 Jan, 2022 | 4 | |
30 Dec, 2021 | SC 13D | |
9 Dec, 2021 | 10-Q | |
9 Dec, 2021 | 8-K | |
3 Nov, 2021 | 4 | |
3 Nov, 2021 | 4 | |
25 Oct, 2021 | SC 13G | |
4 Oct, 2021 | 4 | |
4 Oct, 2021 | 4 | |
4 Oct, 2021 | 8-K | |
1 Oct, 2021 | 4 | |
1 Oct, 2021 | 4 | |
1 Oct, 2021 | 4 | |
1 Oct, 2021 | 4 | |
17 Sep, 2021 | SC 13G | |
15 Sep, 2021 | 8-K | |
9 Sep, 2021 | 8-K | |
9 Sep, 2021 | 10-Q | |
17 Aug, 2021 | DEFA14A | |
17 Aug, 2021 | DEF 14A | |
4 Aug, 2021 | 4 | |
4 Aug, 2021 | 4 | |
13 Jul, 2021 | 8-K | |
13 Jul, 2021 | 10-K | |
13 Jul, 2021 | S-8 | |
2 Jul, 2021 | 4 | |
30 Jun, 2021 | 8-K | |
22 Jun, 2021 | 4 | |
11 Jun, 2021 | 4 | |
10 Jun, 2021 | SC 13G/A | |
7 Jun, 2021 | 8-K | |
3 Jun, 2021 | 4 | |
3 Jun, 2021 | 4 | |
1 Jun, 2021 | EFFECT | |
28 May, 2021 | 4 | |
28 May, 2021 | 4 | |
28 May, 2021 | 4 | |
28 May, 2021 | 4 | |
28 May, 2021 | 4 | |
28 May, 2021 | 4 | |
27 May, 2021 | UPLOAD | |
27 May, 2021 | SC 13G | |
27 May, 2021 | CORRESP | |
21 May, 2021 | S-3 | |
7 May, 2021 | SC 13G | |
7 May, 2021 | 4/A | |
6 May, 2021 | 4 | |
6 May, 2021 | 4 | |
4 May, 2021 | 3 | |
4 May, 2021 | 4 | |
30 Apr, 2021 | 4 | |
29 Apr, 2021 | 4 | |
5 Apr, 2021 | 4 | |
19 Mar, 2021 | 4 | |
19 Mar, 2021 | 3 | |
19 Mar, 2021 | 8-K | |
11 Mar, 2021 | S-8 | |
11 Mar, 2021 | 8-K | |
11 Mar, 2021 | 10-Q | |
25 Feb, 2021 | 4 | |
25 Feb, 2021 | 4 | |
25 Feb, 2021 | 4 | |
25 Feb, 2021 | 4 | |
16 Feb, 2021 | SC 13D/A | |
16 Feb, 2021 | SC 13G/A | |
12 Feb, 2021 | SC 13G/A | |
11 Feb, 2021 | 424B5 | |
11 Feb, 2021 | 8-K | |
10 Feb, 2021 | S-3MEF | |
9 Feb, 2021 | 424B5 | |
8 Feb, 2021 | 4 | |
8 Feb, 2021 | 4 | |
8 Feb, 2021 | SC 13G/A | |
8 Feb, 2021 | 4 | |
8 Feb, 2021 | 4 | |
8 Feb, 2021 | 4 | |
8 Feb, 2021 | 4 | |
2 Feb, 2021 | SC 13G | |
27 Jan, 2021 | 8-K | |
6 Jan, 2021 | 4 | |
4 Jan, 2021 | 4 |
Last update:2024-03-12 12:00:13.104478
Sign Up to Subscribe
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.